GERD Patient Satisfaction Hinges On Medication, Bedside Manner
Posted on: Saturday, 1 August 2009, 08:45 CDT
Patient satisfaction with their medications and the quality of interactions with their doctor reflect the success of gastroesophageal reflux disease (GERD) therapy, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
"Although patient satisfaction is a complex issue, improvements in recognition of GERD can improve management of the disease as well as patient satisfaction with their care and treatment," said Peter Bytzer, MD, PhD, of Copenhagen University and lead author of the study. "Patient satisfaction can be influenced by a number of factors including treatment regimen, general level of well-being, the 'bedside manner' of the physician, the patient's expectations and the quality of patient/physician communication."
The researchers found that patients who were given prescriptions for proton pump inhibitors (PPIs) tended to be more satisfied than those given H2-receptor antagonists. Partial responders were likely to be more dissatisfied than patients whose symptoms were fully resolved. In addition, a decrease in health-related quality of life (HRQoL) was associated with greater dissatisfaction. In fact, decreasing HRQoL was correlated with decreasing satisfaction with medical care in general. Patients were more likely to be satisfied if they were taken seriously by their physician and if their symptoms were investigated. They were also more likely to be satisfied if the patient/physician consultation was interactive.
"Of the various factors influencing patient satisfaction, the quality of patient/physician communication is probably the most amenable to improvement. This can be done by using validated questionnaires to help physicians identify more effectively which symptoms patients have, and the impact of these symptoms on the patient's well-being," added Dr. Bytzer.
Researchers reviewed the possible reasons why patients were dissatisfied with the way their disease is managed. Studies published between 1970 and 2007 were identified from PubMed, EMBASE and the author's existing database; 11 studies were found to be appropriate for use in this review. A key strength of this review was the fact that the searches identified a wide range of studies with varying methodologies.
Typically characterized by frequent or troublesome heartburn and/or acid regurgitation, GERD is a chronic, painful condition that impairs HRQoL. GERD may result in disturbed sleep, reduced productivity at work and impaired daily activities. Despite the efficacy of PPIs as therapeutics for patients with GERD, a number of studies have shown that a proportion of patients with the disease are not satisfied with their treatment. In fact, population-based surveys show that at least one-third of individuals taking medication for GERD are not satisfied with their treatment. This is particularly true for those taking over-the-counter medicines to relieve symptoms.
---
On the Net:
- American Gastroenterological Association
- To learn more about heartburn and GERD, read the AGA patient brochure on this topic at www.gastro.org/patient.
- Clinical Gastroenterology and Hepatology
Related Articles
- OBP Medical Inc. to Raise the Bar in Patient Care and Satisfaction
- First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
- Obstructive Sleep Apnea Patients Have More Occurrences Of Parasomnia Symptoms
- Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
- First Patient Enrolled in SONOMA Post-Market Approval Study of Boston Scientific NexStent(R) Carotid Stent System and FilterWire EZ(TM) Embolic Protection Device
- Synthetic Blood Enrolls First Patient in Phase II Traumatic Brain Injury Study
- Advocacy for Patients With Chronic Illness, Inc. Releases Case Study
- AtriCure Enrolls First Patient in Sole-Therapy Minimally Invasive Clinical Study for the Treatment of Atrial Fibrillation
- Research and Markets: How Depression Management Programs Can Improve Patient Outcomes and Satisfaction and Yield Financial Benefits in Healthcare Costs
- Data on PEG-INTRON(R) and REBETOL(R) Combination Therapy in Diverse Patient Populations to Be Presented at 2005 Digestive Disease Week (DDW) Meeting
 |
 |
User Comments (0)
RSS Feeds